From the Editorial
La Jornada Newspaper
Friday, October 18, 2024, p. 14
The Federal Commission for the Protection against Health Risks (Cofepris) issued an alert for the illegal sale on digital platforms of Combovir (nirmatrelvir 150 mg/ritonavir 100 mg) tablets, manufactured by Bruck Pharma Private Limited, indicated for the treatment of covid-19 . The product lacks health registration in the country, so there is no guarantee about its composition, purity, safety, efficacy and quality. The manufacturing, storage and transportation conditions are also unknown. For these reasons, the drug represents a risk to health, indicated Cofepris and recommended that the population not buy it, and if there is information about its possible commercialization, it is necessary to file a health complaint in www.gob.mx/cofepris/acciones-y-programas/denuncias-sanitarias.
